The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro: Implications for urinary stone formation

Molecular Medicine

Volumn 8, Issue 9, 2002, Pages 525-535

  Grover, Phulwinder K ^a,b   Ryall, Rosemary L ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; URATE; URIC ACID;

ACID PRECIPITATION; ADSORPTION; ADULT; AQUEOUS SOLUTION; ARTICLE; BARNACLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; COULTER COUNTER; CRYSTAL STRUCTURE; CRYSTALLIZATION; DEMINERALIZATION; ENCAPSULATION; HUMAN; HYPERURICOSURIA; MACROMOLECULE; MALE; NORMAL HUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN URINE LEVEL; SCANNING ELECTRON MICROSCOPY; STONE FORMATION; URINE; UROLITHIASIS;

EID: 0036765429     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402162     Document Type: Article

References (53)

1. Ryall RL, Grover PK, Marshall VR. (1991) Urate and calcium stones: picking up a drop of mercury with one's fingers? Am. J. Kidney Dis. 17: 426-430.
2. Grover PK, Ryall RL. (1994) Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner. Electrolyte Metab. 20: 361-370.
3. Grover PK, Ryall RL. (1995) Urate and calcium oxalate stones: A new look at an old controversy. In: Khan SR, (ed.) Calcium Oxalate in Biological Systems. CRC Press, New York and London; 305-321.
4. Coe FL, Raisen L. (1973) Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet 1: 129-131.
5. Coe FL, Kavalach AG. (1974) Hypercalciuria and hyperuricosuriain patients with calcium nephrolithiasis. N. Engl. J. Med. 291: 1344-1350.
6. Smith MJV, Boyce WH. (1969) Allopurinol and urolithiasis. J. Urol. 102: 750-753.
7. Pak CYC, Barilla DE, Holt K, et al. (1978) Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am. J. Med. 65: 593-599.
8. Miano L, Petta S, Gallucci M. (1979) Allopurinol in the prevention of calcium oxalate renal stones. Eur. Urol. 5: 229-232.
9. Maschio G, Tessitore N, D'Angelo A, et al. (1981) Prevention of calcium nephrolithiasis with low dose thiazide, amiloride, and allopurinol. Am. J. Med. 71: 623-626.
10. Smith MJV. (1983) Placebo versus allopurinol for recurrent urinary calculi. Proc. EDTA 20: 422-426.
11. Ettinger B, Tang A, Citron JT, et al. (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N. Engl. J. Med. 315: 1386-1389.
12. Royer L. (1928) Experimental research on parallel growth on mutual orientation of crystals of different species. Bull. Soc. Fr. Mineral. 51: 7-159.
13. Modlin M. (1967) The aetiology of renal stones: A new concept arising from studies in a stone-free population. Ann. R. Coll. Surg. Engl. (London) 40: 155-178.
14. Lonsdale K. (1968) Epitaxy as a growth factor in urinary calculi and gallstones. Nature 217: 56-58.
15. Coe FL, Lawton RN, Goldstein RB, Tembe V. (1975) Sodium urate accelerates precipitation of calcium oxalate in vitro. Proc. Soc. Exp. Biol. Med. 149: 926-929.
16. Pak CYC, Arnold LH. (1975) Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc. Soc. Exp. Biol. Med. 149: 930-932.
17. Meyer JL, Bergert JH, Smith LH. (1976) The epitaxially induced crystal growth of calcium oxalate by crystalline uric acid. Invest. Urol. 14: 115-119.
18. Koutsoukos PG, Lam-Erwin CY, Nancollas GH. (1980) Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system. Invest. Urol. 18: 178-184.
19. Mandel NS, Mandel GS. (1981) Epitaxis between stone-forming crystals at atomic level. In: Smith LH, Robertson WG and Finlayson B (eds.) Urolithiasis: Clinical and Basic Research. Plenum Press, New York and London, 469-480.
20. Hartung R, Leskovar P, Kratzer M. (1981) Mechanisms of the influence of uric acid on the precipitation of Ca-oxalate crystals out of metastable solution. Croat. Chim. Acta 53: 381-388.
21. Deganello S, Coe F. (1983) Epitaxy between uric acid and whewellite: experimental verification. N. Jb. Miner. Mh. 6: 270-276.
22. Deganello S, Chou C. (1984) The uric acid-whewellite association in human kidney stones. Scan. Electron Microsc. II: 927-933.
23. Sarig S, Hirsch D, Garti N, Goldwasser B. (1984) An extension of the concept of epitaxial growth. J. Crystal Growth 69: 91-95.
24. Tiselius HG. (1984) Effects of sodium urate and uric acid crystals on the crystallization of calcium oxalate. Urol. Res. 12: 11-15.
25. Grases F, Conte A, Gil JJ. (1988) Simple method for the study of heterogeneous nucleation in calcium oxalate urolithiasis. Br. J. Urol. 61: 468-473.
26. Sikiric M, Babic-Ivancic V, Tonkovic M. (1997) Precipitation of calcium oxalate and calcium phosphate in the presence of uric acid. Colloids Surfaces A: Physicochem. Eng. Aspects 121: 145-150.
27. Grover PK, Ryall RL. (1997) Effect of seed crystals of uric acid and monosodium urate on the crystallization of calcium oxalate in undiluted human urine in vitro. Clin. Sci. 92: 205-213.
28. Ryall RL. (1996) Glycosaminoglycans, proteins, and stone formation: adult themes and child's play. Pediatr. Nephrol. 10: 656-666.
29. Doyle IR, Ryall RL, Marshall VR. (1991) Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin. Chem. 37: 1589-1594.
30. Heukeshoven J, Dernick R. (1985) Simplified method for silver-staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis 6: 103-112.
31. Stapleton AMF, Simpson RJ, Ryall RL. (1993) Crystal matrix protein is related to human prothrombin. Biochem. Biophys. Res. Commun. 195: 1199-1203.
32. Stapleton AMF, Ryall RL. (1995) Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin. Br. J. Urol. 75: 712-719.
33. Dent CE, Sutor DJ. (1971) Presence or absence of an inhibitor of calcium oxalate crystal growth in urine of normals and stone-formers. Lancet ii: 775-778.
34. Pak CYC, Hayashi Y, Arnold LH. (1976) Heterogeneous nucleation with urate, calcium phosphate and calcium oxalate. Proc. Soc. Exp. Biol. Med. 153: 83-87.
35. Pak CYC, Holt K, Britton F, et al. (1980) Assessment of pathogenetic role of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis. Miner. Electrolyte Metab. 4: 130-136.
36. Ryall RL. (1997) Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J. Urol. 15: 155-164.
37. Doyle IR, Ryall RL, Marshall VR. (1989) The effect of low speed centrifugation and millipore filtration on the urinary protein content. In: Walker VR, Sutton RAL, Cameron ECB, Pak CYC, Robertson WG (eds.) Urolithiasis. New York: Plenum Press; 593-594.
38. Ryall RL, Harnett RM, Hibberd CM, et al. (1991) Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine. Urol. Res. 19: 181-188.
39. Burns JR, Finlayson B. (1980) The effect of seed crystals on calcium oxalate nucleation. Invest. Urol. 18: 133-136.
40. Meyer JL. (1981) Nucleation kinetics in the calcium oxalate-sodium urate monohydrate system. Invest. Urol. 19: 197-201.
41. Iwata H, Kamei O, Abe Y, et al. (1988) The organic matrix of urinary uric acid crystals. J. Urol. 139: 607-610.
42. Morse RM, Resnick MI. (1989) A study of the incorporation of urinary macromolecules onto crystals of different mineral compositions. J. Urol. 141: 641-644.
43. Ryall RL, Grover PK, Stapleton AMF. (1995) The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. Clin. Sci. 89: 533-541.
44. Grover PK, Ryall RL. (1999) Inhibition of calcium oxalate growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity. Eur. J. Biochem. 263: 50-56.
45. Burnier JP, Borowski M, Furie BC, Furie B. (1981) Gamma-carboxyglutamic acid. Mol. Cellular Biochem. 39: 191-199.
46. Kalaiselvi P, Udayapriya KL, Selvam R. 1999) Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization. BJU Int. 83: 919-923.
47. McCulloch RK, Bowyer RC, Brockis JW. (1981) Possible roles of urate in calcium urolithiasis. In: Brockis JG and Finlayson B (eds.) Urinary Calculus. PSG Publishing Company Inc., Littleton, Massachusetts; 347-352.
48. Grover PK, Ryall RL, Marshall VR. (1990) Effect of urate on calcium oxalate crystallization in human urine: evidence for a promotory role of hyperuricosuria in urolithiasis. Clin. Sci. 79: 9-15.
49. Grover PK, Ryall RL, Marshall VR. (1992) Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kidney Int. 41: 149-154.
50. Robertson WG, Knowles F, Peacock M. (1976) Urinary mucopolysaccharide inhibitors of calcium oxalate crystallization. In: Fleisch H, Robertson WG, Smith LH and Vahlensieck W (eds.) Urolithiasis Research. Plenum Press, New York and London; 331-334.
51. Grover PK, Ryall RL, Marshall VR. (1993) Dissolved urate promotes calcium oxalate crystallization: epitaxy is not the cause. Clin. Sci. 85: 303-307.
52. Kallistratos G, Timmermann A, Fenner O. (1970) Zum Einfluss des Aussalzeffektes auf die Bildung von calciumoxalat-Kristallen im menschlichen Harn. Naturwissenschaften 57: 198.
53. Kallistratos G, Timmermann A. (1971) The "salting-out" effect as a possible causative factor for the formation of calcium oxalate crystals in human urine. Paper presented at the 66th annual meeting of the American Urological Association in Chicago, Illinois, USA, May 17, 1971, Urological Research Forum.